Ulcerative Colitis Clinical Trials near Cincinnati, OH
15 studies for Ulcerative Colitis are recruiting at 21 sites within 50 miles of Cincinnati, Ohio, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Ulcerative Colitis trials in the US or all trials near Cincinnati.
Recruiting now
Ulcerative Colitis studies enrolling near Cincinnati
- A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
NCT06581328
- Phase 4
- Ages 18 to 80 years
- Sex: All
Nearest sites: Gastro Health Research - Cincinnati (Cincinnati, OH); Tri-State Gastroenterology Associates (Crestview Hills, KY)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 5 sites within 50 mi
- A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
NCT07113522
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest sites: Mirador Therapeutics Selected Site (Cincinnati, OH); Mirador Therapeutics Selected Site (Liberty Township, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
NCT06095128
- Phase 4
- Ages 18 to 65 years
- Sex: All
Nearest site: University of Cincinnati (Cincinnati, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
NCT06398626
- Observational
- Ages 18 to 64 years
- Sex: All
Nearest site: University of Cincinnati College of Medicine (Cincinnati, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
NCT06663332
- Phase 3
- Ages 3 years and older
- Sex: All
Nearest site: Cincinnati Children's Hospital Medical Center (Cincinnati, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Evaluation of the SMART IBD App in Pediatric IBD
NCT07195123
- Interventional
- Ages 13 to 17 years
- Sex: All
Nearest site: Cincinnati Children's Hospital Medical Center (Cincinnati, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Zymfentra (Infliximab-dyyb) REal World Cohort STudy
NCT07237516
- Observational
- Ages 18 years and older
- Sex: All
Nearest site: University of Cincinnati (Cincinnati, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
NCT07196748
- Phase 3
- Ages 12 years and older
- Sex: All
Nearest site: Tri-State Gastroenterology Assoc (Crestview Hills, KY)
- Distance to nearest recruiting site
- ~8 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07577856
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: Tri-State Gastroenterology Assoc (Crestview Hills, KY)
- Distance to nearest recruiting site
- ~8 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07184996
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest sites: DSI Research, LLC - Site Number: 8400105 (Springboro, OH); DSI Research, LLC - Site Number: 8400115 (Dayton, OH)
- Distance to nearest recruiting site
- ~33 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest site: DSI Research, LLC d/b/a ObjectiveHealth Clinical Research - Springboro (Springboro, OH)
- Distance to nearest recruiting site
- ~33 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
NCT06619990
- Phase 1/2
- Ages 18 to 75 years
- Sex: All
- Accepts healthy volunteers
Nearest site: Xencor Investigative Site (Beavercreek, OH)
- Distance to nearest recruiting site
- ~47 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
NCT07697456
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: Dayton Gastroenterology - Beavercreek /ID# 284065 (Beavercreek, OH)
- Distance to nearest recruiting site
- ~47 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
NCT07186101
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest site: Dayton Gastroenterology, LLC (Dayton, OH)
- Distance to nearest recruiting site
- ~47 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07845487
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: Site US-023 (Dayton, OH)
- Distance to nearest recruiting site
- ~47 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining an Ulcerative Colitis clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.